1. Home
  2. EWCZ vs HRTX Comparison

EWCZ vs HRTX Comparison

Compare EWCZ & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EWCZ
  • HRTX
  • Stock Information
  • Founded
  • EWCZ 2004
  • HRTX 1983
  • Country
  • EWCZ United States
  • HRTX United States
  • Employees
  • EWCZ N/A
  • HRTX N/A
  • Industry
  • EWCZ Package Goods/Cosmetics
  • HRTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EWCZ Consumer Discretionary
  • HRTX Health Care
  • Exchange
  • EWCZ Nasdaq
  • HRTX Nasdaq
  • Market Cap
  • EWCZ 300.3M
  • HRTX 270.7M
  • IPO Year
  • EWCZ 2021
  • HRTX 1987
  • Fundamental
  • Price
  • EWCZ $6.39
  • HRTX $1.77
  • Analyst Decision
  • EWCZ Buy
  • HRTX Strong Buy
  • Analyst Count
  • EWCZ 7
  • HRTX 3
  • Target Price
  • EWCZ $6.64
  • HRTX $5.67
  • AVG Volume (30 Days)
  • EWCZ 360.7K
  • HRTX 1.1M
  • Earning Date
  • EWCZ 03-05-2025
  • HRTX 02-27-2025
  • Dividend Yield
  • EWCZ N/A
  • HRTX N/A
  • EPS Growth
  • EWCZ 62.57
  • HRTX N/A
  • EPS
  • EWCZ 0.23
  • HRTX N/A
  • Revenue
  • EWCZ $223,500,000.00
  • HRTX $137,737,000.00
  • Revenue This Year
  • EWCZ $1.26
  • HRTX $13.10
  • Revenue Next Year
  • EWCZ $2.40
  • HRTX $14.03
  • P/E Ratio
  • EWCZ $28.26
  • HRTX N/A
  • Revenue Growth
  • EWCZ 2.42
  • HRTX 12.13
  • 52 Week Low
  • EWCZ $4.80
  • HRTX $1.04
  • 52 Week High
  • EWCZ $15.50
  • HRTX $3.93
  • Technical
  • Relative Strength Index (RSI)
  • EWCZ 41.42
  • HRTX 54.82
  • Support Level
  • EWCZ $6.74
  • HRTX $1.65
  • Resistance Level
  • EWCZ $7.60
  • HRTX $1.83
  • Average True Range (ATR)
  • EWCZ 0.33
  • HRTX 0.10
  • MACD
  • EWCZ -0.10
  • HRTX -0.00
  • Stochastic Oscillator
  • EWCZ 5.30
  • HRTX 54.84

About EWCZ European Wax Center Inc.

European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: